Olopatadine Hydrochloride Spray
Product Images NDC 45802-104

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 45802-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural (01 04 17 4s0 Structural Formula)

Chemical structure of olopatadine hydrochloride, displaying its molecular arrangement including aromatic rings, an ether linkage, a carboxylic acid group, and a dimethylamino side chain with associated hydrochloride (HCl) salt.*

FDA Label Image

Figure-a (Image 02)

An instructional diagram illustrating the components of the olopatadine hydrochloride nasal spray, including the cap, shoulder, nasal applicator, and clip. Each part is labeled with arrows pointing to the respective section of the spray bottle and its clip accessory.*

FDA Label Image

Figure-b (Image 03)

An instructional illustration showing a hand holding a nasal spray bottle upright with the index finger pressing the nozzle to administer olopatadine hydrochloride nasal spray.*

FDA Label Image

Figure-c (Image 04)

An instructional illustration showing a woman administering a nasal spray. She is holding the spray bottle and inserting the nozzle into one nostril while tilting her head slightly backward.*

FDA Label Image

Figure-d (Image 05)

An instructional illustration showing a hand wiping the nasal spray bottle with a cloth or tissue. The spray bottle fits within the hand, emphasizing cleaning or preparation of the olopatadine hydrochloride nasal spray device.*

FDA Label Image

Figure-e (Image 06)

An instructional illustration showing a hand holding a nasal spray bottle labeled olopatadine hydrochloride 665 mcg/1 spray. Another hand is removing or attaching a protective cap from the spray nozzle, indicating how to prepare the nasal spray for use.*

FDA Label Image

Figure-f (Image 07)

An instructional illustration showing one hand holding a nasal spray bottle and the other hand removing the nasal spray cap, demonstrating how to prepare the spray for use.*

FDA Label Image

Figure-g (Image 08)

An instructional illustration showing a person rinsing a nasal spray device under running water from a faucet. The spray nozzle is being cleaned by holding it under the water stream.*

FDA Label Image

Carton (Carton)

Packaging label for Olopatadine Hydrochloride Nasal Spray, 665 mcg per spray, by Padagis Israel Pharmaceuticals Ltd. The carton indicates a metered spray dosage form with 240 metered sprays per container and a net weight of 30.5 g. Instructions and ingredients including active ingredient olopatadine hydrochloride and preservative benzalkonium chloride are printed along with dosage guidelines and storage conditions.*

FDA Label Image

Serialization-template.jpg (Serialization Template)

A product labeling panel showing space for serial number (S/N), lot number (Lot), and expiration date (Exp) for olopatadine hydrochloride nasal spray. The panel includes placeholders indicating where to insert the product’s specific serial number, lot number, and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.